3月19日 - ** 药物开发商Cargo Therapeutics CRGX.O股价盘前上涨21%，至4.60美元
** 该公司周二表示， (link)，将裁员约90%
** CRGX任命Anup Radhakrishnan为临时首席执行官，带领公司完成潜在的并购交易
** 截至2024年12月31日，公司约有167名全职员工 (link) - SEC备案
** 公司还表示将停止CRG-023实验性癌症疗法和异体平台
** 今年早些时候，公司停止了 (link) 一项癌症治疗的中期试验
** 截至2024年12月31日，CRGX拥有3.681亿美元的现金
** CRGX去年下跌36.5
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.